We are live on ! Find out more
BOUT icon

CapForce IBD Breakout Opportunities ETF

9 hedge funds and large institutions have $1.01M invested in CapForce IBD Breakout Opportunities ETF in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

13% more funds holding

Funds holding: 89 (+1)

2.04% less ownership

Funds ownership: 9.24%7.2% (-2%)

18% less capital invested

Capital invested by funds: $1.23M → $1.01M (-$220K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

BOUT Hedge Fund Activity: Q1 2023 in Review

9 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD Breakout Opportunities ETF (BOUT) for Q1 2023, worth a combined $1.01M — down 18% from $1.23M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new BOUT positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Ahrens Investment Partners, opening a new position worth an estimated $13.1K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $217K sold.

  • 9 institutional investors held CapForce IBD Breakout Opportunities ETF (BOUT) as of Q1 2023, up from 8 in Q4 2022.
  • Funds reported $1.01M of CapForce IBD Breakout Opportunities ETF stock for Q1 2023, down 18% quarter-over-quarter.
  • 2 funds opened new CapForce IBD Breakout Opportunities ETF positions in Q1 2023 and 1 closed out, a net change of +1 holder.
  • The largest CapForce IBD Breakout Opportunities ETF buyer in Q1 2023 was Ahrens Investment Partners, an estimated $13.1K added.
  • The largest CapForce IBD Breakout Opportunities ETF seller in Q1 2023 was Susquehanna International Group, an estimated $217K sold.

Based on aggregated 13F filings for Q1 2023.